Skip to main content
. 2021 Feb 18;14(2):162. doi: 10.3390/ph14020162

Figure 3.

Figure 3

Comparison of the performance of several sampling strategies to predict ibrutinib AUC in the development (top) and validation (bottom) dataset. Crosses (+) are out of bound values censored to the maximal bound of the y-axis (i.e., +/−60%).